MannKind Corp
MNKD
#6155
Rank
โ‚น102.32 B
Marketcap
โ‚น318.24
Share price
-3.80%
Change (1 day)
-26.53%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -โ‚น12.19

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -โ‚น12.57. In 2025 the company made an earnings per share (EPS) of โ‚น1.93 a decrease over its 2024 EPS that were of โ‚น9.67.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น12.19-730.24%
2025โ‚น1.93-80%
2024โ‚น9.67
2022-โ‚น32.896.25%
2021-โ‚น30.9528%
2020-โ‚น24.18-7.41%
2019-โ‚น26.12
2017-โ‚น107.37-188.1%
2016โ‚น121.88-128.31%
2015-โ‚น430.4574.51%
2014-โ‚น246.66-20.31%
2013-โ‚น309.54-32.63%
2012-โ‚น459.47-28.03%
2011-โ‚น638.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น73.51-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น394.43-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น2,891-23,087.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น122.41-1,073.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น340.49-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น648.09 5,053.85%๐Ÿ‡บ๐Ÿ‡ธ USA